Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study

OBJECTIVE: Several studies have demonstrated different benefits for patients whose disease progressed despite previous trastuzumab treatment. Due to limited real-world data, we evaluate the effectiveness of anti-human epidermal growth factor receptor 2 (HER2) therapy (lapatinib or trastuzumab) plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wei, Bian, Li, Wang, Tao, Zhang, Shaohua, Li, Jianbin, Xu, Fengrui, Jiang, Zefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369172/
https://www.ncbi.nlm.nih.gov/pubmed/32694900
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.03.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369172/
https://www.ncbi.nlm.nih.gov/pubmed/32694900
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.03.07

Ejemplares similares